Moloxin (Moxifloxacin)

Moxifloxacin blocks bacterial DNA gyrase and topoisomerase IV, enzymes needed for DNA replication and transcription. By preventing DNA strand separation and resealing, it stops bacterial cell division, leading to rapid bactericidal activity against a broad range of Gram‑positive and Gram‑negative organisms.

The specific dose of Moloxin is determined by the prescribing clinician based on the infection type, severity, patient age, renal function, and other clinical factors. Standard adult regimens are outlined in national guidelines, but the exact amount and duration must be individualized by a qualified health professional.

Moxifloxacin is classified as Pregnancy Category C, indicating that risk to the fetus cannot be ruled out and it should only be used if the potential benefit justifies the potential risk. Limited data are available for breastfeeding; caution is advised and the drug should be used only if clearly needed.

To request Moloxin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and assistance with import documentation.

Moloxin (moxifloxacin) offers a broader spectrum against both Gram‑positive and Gram‑negative bacteria compared with older fluoroquinolones such as levofloxacin, and it has enhanced activity against atypical respiratory pathogens. However, safety considerations like tendon toxicity and QT prolongation are similar across the class, so choice depends on susceptibility patterns and patient risk factors.

Moloxin tablets should be stored at room temperature, below 25 °C, in the original blister pack to protect from moisture and light. Keep the container tightly closed and out of reach of children. Do not store in humid or excessively hot environments.

Moloxin is administered orally, usually with a full glass of water. It may be taken with or without food, but antacids containing aluminum or magnesium should be spaced at least two hours apart to avoid reduced absorption. Patients should follow the prescriber’s instructions regarding timing and duration.

Serious adverse events include tendon rupture (especially Achilles), QT interval prolongation leading to arrhythmias, severe allergic reactions such as anaphylaxis, Clostridioides difficile‑associated colitis, and significant liver enzyme elevations. Patients should seek immediate medical attention if they experience sudden tendon pain, palpitations, severe rash, or persistent diarrhea.

Moloxin is contraindicated in individuals with a known hypersensitivity to moxifloxacin or any fluoroquinolone. It should be avoided in patients with a history of tendon disorders related to fluoroquinolone use, uncontrolled epilepsy, or those taking other QT‑prolonging drugs without careful monitoring. Use is generally not recommended in children and adolescents unless specifically indicated.